BCAB vs FAST · $5.9M cap vs P/E 43, rev $7.55B
Bioatla Inc (BCAB) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
BCAB currently screens at market cap $5.9M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the BCAB and FAST stock pages for the full models.
Not investment advice.